Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a glass of water tame your stress hormones?

NCT ID NCT07789847

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This trial tests whether changing how much water people drink each day affects how their body releases cortisol, a stress hormone, during a stressful situation. Healthy adults will either keep their usual fluid intake, drink more if they usually drink little, or drink less if they usually drink a lot, for one week. Then researchers measure cortisol levels in saliva during a stress test. The goal is to see if hydration status can influence the body's stress response, which may help explain links between low fluid intake and long-term health risks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Modifying daily total fluid intake (water drinking habits)
What this could lead to
If it works, this could show that staying well-hydrated helps dampen the body's stress response, pointing toward a simple way to support long-term health.
What could go wrong
This is an early-stage trial, and changing water intake may not meaningfully change stress hormone responses. Results may also not apply to everyone, especially those with health conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 192 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals who… * …are free-living, who fully understand and agree to the objectives of the study, who gave, signed and dated informed consent, which includes compliance with the requirements and restrictions listed in the informed consent form and in this protocol. * …are 'healthy' men and current combined oral contraceptive (COC)-using women (having taken the COC for at least 3 months and should they be eligible and willing to participate, are happy to continue taking the same COC during the duration of their participation). * …are aged 18-35 years * …engage in \< 5 hours of vigorous exercise a week. This information will be obtained during the initial study brief and using the health screening questionnaire. * …have a habitual fluid consumption of ≤ 1.6 L/day OR ≥ 2.9 L/day for men and ≤ 1.5 L/day OR ≥ 2.5 L/day for women, verified by a 7-day fluid intake record. * …have a day-to-day variation in fluid intake of ≤ 25%. * …have a verified UOsm aligned with the following: * IF habitual low TFI, i.e., TFI ≤ 1.5 L/day for women OR ≤ 1.6 L/day for men have a UOsm ≥ 500 mOsm/kg. * IF habitual high TFI, i.e., TFI ≥ 2.5 L/day for women OR ≥ 2.9 L/day for men have a UOsm \< 500 mOsm/kg. * …have a day-to-day variation in UOsm ≤ 28%; UOsm screening will be determined during verification and intervention periods. * …have access to a domestic fridge at home so that urine samples can be stored prior to laboratory visits. * …have a body mass index (BMI) \< 30 kg/m². * …have an IOS or Android smart phone and therefore the ability to download the HidrateSpark mobile application. Exclusion Criteria: * Individuals who… * …are vulnerable, as defined by individuals whose willingness to volunteer in the study may be unduly influenced by the expectation, whether justified or not, of benefits associated with participation, or of a retaliatory response from senior members of a hierarchy in case of refusal to participate (for example, if members of a group with a hierarchical structure linked to the investigator or to the sponsor, subordinate laboratory personnel, and employees of the investigator or sponsor. * …are not able to answer questionnaires by writing whatever the reason. * …have a loss of personal liberty, by administrative or judicial decision. * …engage in \> 5 hours of vigorous exercise a week. * …engage in endurance exercise bouts lasting longer than 40 minutes. * …do not have access to a domestic fridge at home so that urine samples can be stored prior to laboratory visits. * …do not have an IOS or Android smart phone and therefore do not have the ability to download the HidrateSpark application. * …are currently participating in another relevant clinical study (e.g., likely to influence hydration status or stress responsivity). * …have completed the TSST before. * …are expected to be living in the same home as a current participant. Health screening Individuals who… * …have had any surgery or medical procedure requiring a general anaesthesia in the preceding 4 weeks, or who plan to have one during the study. * …have an ongoing clinically diagnosed medical condition. * …are currently taking prescribed medication for an ongoing medical condition. * …are clinically diagnosed with one of the following psychiatric disorders known to influence stress reactivity: melancholic or atypical depression; panic disorder; obsessive-compulsive disorder; schizophrenia; social or generalised anxiety disorder; autism spectrum disorder; post-traumatic stress disorder; psychosis. * …have a clinically diagnosed sleeping disorder. * …are a current smoker (including e-cigarettes and vapes). * …have had a respiratory or gastrointestinal infection within the last 2 weeks. * …have a clinically diagnosed eating disorder. * …have a special medicated diet (e.g., for obesity, anorexia, metabolic pathology). * …have changed their dietary habits within the last 4 weeks or plan to change their diet during the study (e.g., start of a high-fibre diet, intentionally reducing or increasing calorie intake). * …take dietary supplements known to influence stress reactivity (e.g., high-dose caffeine). * …are women not currently on COC (e.g., naturally menstruating, or on progestogen-only forms of contraception, such as IUS, mini-pill, implant or injection). * …are women currently using COC but for \< 3 months prior to reading the participant information sheet or not planning to continue taking COC during their potential participation in the study. * …are pregnant women or women planning to become pregnant during the study or are breast-feeding women. Total fluid intake screening Individuals who… * …have a daily total fluid intake of: * Men: between 1.6 and 2.9 L/day. * Women: between 1.5 and 2.5 L/day. * …have a day-to-day variation in fluid intake of \>25%. * …have a UOsm of: * Men: \< 500 mOsm/kg if habitual TFI is ≤ 1.6 L.day or ≥ 500 mOsm/kg if habitual TFI is ≥ 2.9 L/day. * Women: \< 500 mOsm/kg if habitual TFI is ≤ 1.5 L/day or ≥ 500 mOsm/kg if habitual TFI is ≥ 2.5 L/day. * …have a day-to-day variation in UOsm \> 28%. * …habitually consume \> 1.3 L/day of caffeinated hot beverages (e.g., tea, coffee; 1.3 L equates to 4 average sized mugs) as estimated by a fluid intake record questionnaire. * …consume ≥ 91 units of alcohol per month (equivalent to more than 3 pints of beer per day or more than 3 large glasses of red wine per day).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fluid intake are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Liverpool John Moores University

    RECRUITING

    Liverpool, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.